Bristol-Myers Squibb (BMY) | Stock Overview & Key Data
Bristol-Myers Squibb Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $81.44 on November 28, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119.87B Large-cap | 1.21% | -1.33% | -5.81% | 3.59% | 5.20% | 14.83% | -13.65% | -14.05% | -19.16% | 107.59% | 126.89% | |
|
Eli Lilly and
LLY
|
821.31B Mega-cap | -1.72% | 12.38% | 14.18% | 6.32% | 4.53% | 38.28% | 153.07% | 418.42% | 1,433.98% | 2,935.09% | 1,988.48% |
| 555.84B Mega-cap | 1.51% | 3.95% | -3.10% | 10.03% | 13.65% | 53.32% | 46.67% | 48.70% | 108.58% | 263.36% | 290.52% | |
|
Amgen
AMGN
|
187.93B Large-cap | 1.39% | 7.42% | -4.29% | 7.75% | 6.99% | 20.32% | 54.66% | 48.82% | 137.40% | 512.31% | 431.58% |
|
Gilead Sciences
GILD
|
165.87B Large-cap | -2.97% | -4.07% | -14.40% | 3.77% | 2.22% | 14.19% | 59.26% | 88.55% | 51.95% | 535.26% | 767.93% |
|
Pfizer
PFE
|
153.59B Large-cap | 1.48% | 2.65% | -2.29% | -1.63% | 3.26% | 6.81% | -34.57% | -32.47% | -19.28% | 36.37% | 17.90% |
Ownership & Short Interest
Calculate Your Bristol-Myers Squibb Investment Returns
Long-Term Investment Performance Analysis
Bristol-Myers Squibb stock price in Jul 2016 was $75.68, A $1,000.00 lump sum investment in Bristol-Myers Squibb made 9 years ago would be worth approximately $743.13 today, representing a negative return of -25.69%. This translates to an annualized return (CAGR) of -2.95%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is BMY's 52-week high and low?
- In the last 52 weeks, Bristol-Myers Squibb reached a high of $62.89 (on March 2, 2026) and a low of $42.52 (on October 29, 2025).
- What is the market cap and P/E ratio for BMY?
- Curious about Bristol-Myers Squibb's size and valuation? Its market capitalization stands at 119.87B. When it comes to valuation, the P/E ratio (trailing twelve months) is 17.06, and the forward P/E (looking ahead) is 9.61.
- Does BMY pay dividends? If so, what's the yield?
- Yes, Bristol-Myers Squibb is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 5.82%, and the company has paid an average of $2.60 per share annually over the past 3 years.
- Who are Bristol-Myers Squibb's main competitors or similar companies to consider before investing?
When looking at Bristol-Myers Squibb, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Eli Lilly and
LLY821.31B Healthcare Drug Manufacturers - General 38.28% 153.07% Johnson & Johnson
JNJ555.84B Healthcare Drug Manufacturers - General 53.32% 46.67% Amgen
AMGN187.93B Healthcare Drug Manufacturers - General 20.32% 54.66% Gilead Sciences
GILD165.87B Healthcare Drug Manufacturers - General 14.19% 59.26% Pfizer
PFE153.59B Healthcare Drug Manufacturers - General 6.81% -34.57% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Bristol-Myers Squibb Company? (e.g., ROE, Debt/Equity)
- To get a sense of Bristol-Myers Squibb's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 40.44%, the Debt to Equity ratio from the most recent quarter is 254.98, and its Gross Profit Margin stands at 67.23%.
- What is the recent revenue and earnings growth for BMY?
- Looking at Bristol-Myers Squibb's growth, its revenue over the trailing twelve months (TTM) was $48B. Compared to the same quarter last year (YoY), quarterly revenue grew by 1.30%, and quarterly earnings saw a YoY growth of 1,409.70%.
- How much of BMY stock is held by insiders and institutions?
- Wondering who owns Bristol-Myers Squibb stock? Company insiders (like executives and directors) hold about 0.09% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 83.86%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.